Sloan Holdings

Sloan Holdings is a private specialty pharmaceutical company that operates primarily through its subsidiary, Sloan Pharma. The company focuses on identifying, developing, and commercializing high-value therapeutic products, with a particular emphasis on the Central Nervous System (CNS) and orphan diseases. Sloan Holdings often utilizes strategic partnerships to apply innovative drug delivery technologies to existing molecules, improving patient compliance and efficacy. A key achievement of the company is its collaboration on the development of Sympazan (clobazam) oral film for seizures associated with Lennox-Gastaut syndrome. The company maintains a lean operational model, focusing on intellectual property and late-stage development.